Licensing tribunal ilianza saa nne asubuhi kwa sababu hakuna upande uliotaka kusubiri usiku mwingine wa surge. Panel ya watu watatu ilikaa juu ya jukwaa dogo. Adrian Vale alikuwa upande wa Nocturne pamoja na counsel wake; Maira alikuwa nyuma yake, uso wake ukiwa mgumu kusoma. Zawadi aliwakilisha Board record. Leila alikuwa technical witness kwa sehemu zilizokuwa ndani ya competence yake.
Adrian alianza si kwa kukataa kila tatizo, bali kwa kitu ambacho kilifanya case kuwa ngumu zaidi.
“Nocturne haikuunda mabadiliko ya usiku,” alisema. “Tuna records za miaka mingi kabla ya kampuni hii. Centralized care iliwekwa kwa sababu errors za decentralized dosing ziliua watu.”
Counsel wake akaweka files za historical episodes kwenye exhibit table. Zilikuwa na tarehe za zamani, kabla ya Calm-X mpya, kabla hata Nocturne haijapanuka.
Panel chair akamgeukia Leila. “Unapinga hilo?”
Leila alitazama files. “Sina msingi wa kupinga kwamba syndrome ilikuwepo kabla ya current formulation. Lab review yetu pia haijathibitisha Nocturne kuwa origin ya syndrome.”
Adrian akamsogelea kwa macho. Alitarajia labda atakwepa. Badala yake alikubali fact inayosaidia upande wake.
“Basi kwa nini mnataka kuvunja mfumo pekee uliowahi ku-manage risk hii kwa scale?” aliuliza.
“Kwa sababu origin ya syndrome na safety ya formulation mpya ni maswali tofauti,” Leila alisema. “Na access control pamoja na reporting gap ni maswali mengine tofauti.”
Panel ikaruhusu lab summary iingie. Zawadi alieleza boundaries: sensitizer marker ilikuwa juu kwenye current formula kuliko old comparator; compatible adverse events zilikuwa zimeonekana; causation ya kila case haijathibitishwa. Kisha surge logs zikaonyesha hospitali tatu ziliweza kutoa care chini ya shared protocol bila central Nocturne approval kwa kila dozi.
Adrian hakurudi nyuma. “Siku moja ya emergency improvisation si safety architecture.”
“Ndiyo,” Leila akasema. “Ndiyo maana tunataka temporary multi-license regime yenye audit, si permanently lawless distribution.”
Counsel wa Nocturne akasema licensed pharmacies zilikuwa zimepata K-17 kwa formula ambayo kampuni ilifadhili. “Mkiifanya open, incentive ya innovation inaenda wapi?”
Panel chair akamkatiza. “Leo tunasikiliza interim safety remedy, si compensation framework ya mwisho.”
Maira aliandika kitu kwenye notepad. Adrian hakumtazama.
Kisha hearing ikahamia kwenye reporting chronology. Zawadi akaweka internal signal memo ya wiki sita kabla ya expansion, approval packet na notice ya “non-material pending study.”
Panel member mmoja akauliza, “Signal hii iliripotiwa kwa Board lini?”
Nocturne counsel akaomba minute ya consultation.
Adrian akasema, “Signal haikuwa confirmed harm. Technical team iliamua monitoring iendelee.”
“Swali ni lini Board ilipata taarifa,” panel member akasema.
Counsel akatoa tarehe. Ilikuwa baada ya expansion kuanza.
Hakukuwa na kishindo. Hakuna mtu aliyepiga kelele. Lakini gap hiyo ilikaa chumbani kama kitu kizito.
Adrian akaomba kuwasilisha historical case file nyingine. “Hii ndiyo context ya centralization. Miaka kumi na moja iliyopita, patient mmoja alipokea compounded stabilizers kutoka clinics tatu. Records hazikushirikiana. Aliingia crisis.”
Leila alisoma summary. Aliweza kuona logic ya Adrian. Portable records hazikuwepo wakati huo. Dosing duplication ilikuwa risk halisi ndani ya ulimwengu wao.
“Centralization ilitatua fragmentation,” Adrian alisema. “Mnanitaka niombe radhi kwa kutengeneza mfumo uliokumbuka patient wakati clinics hazikukumbuka.”
Leila akasema, “Sikuombi uombe radhi kwa continuity. Ninasema continuity haipaswi kuhitaji exclusivity ya kampuni moja, debt account moja na data gate moja.”
Panel chair akauliza remedy yake.
“Emergency multi-license kwa siku thelathini. K-17 na verified stabilizer protocols zipatikane kwa licensed network. Shared clinical ID isiwe tied kwa Nocturne membership. Adverse-event reporting iende Board moja kwa moja. Nocturne ibaki supplier na technical participant, lakini si gatekeeper pekee.”
Adrian akasema, “Ukifanya hivyo na patient afe kwa error ya pharmacy nyingine?”
“Ndiyo maana kuna qualification, audit, dosing matrix na shared alert. Risk haiishi. Inasambazwa na kuonekana.”
Kabla hearing kusimama, panel member wa pili aliuliza swali la practical control. “Mkiwa na licenses nyingi, nani anazuia clinic moja kutoa dose mbili kwa patient aliyehamia site nyingine?”
Adrian akasema, “Huo ndio msingi wa registry yetu.”
Leila akajibu, “Shared clinical ID na cross-clinic dose alert inaweza kufanya kazi bila account kuwa mali ya provider mmoja. Surge ya jana tayari ilizuia duplicate dose kwa shared log.”
“Lakini hiyo ilikuwa temporary.”
“Ndiyo. Interim order inaweza kuifanya requirement badala ya favor ya kampuni.”
Panel ikaomba Board iwasilishe ndani ya saa ishirini na nne minimum data fields kwa portable identity: clinical ID, current protocol, last dose, allergies, consent flags. Debt na marketing fields zisiwe sehemu ya safety minimum. Adrian hakupenda, lakini hakuweza kusema safety ilihitaji outstanding balance ionekane kwa pharmacist wa emergency.
Hearing ilisimama kwa dakika thelathini. Leila alitoka corridor na kukuta Samwel ametuma message: Nuru stable, anaendelea recovery, no major episode since stadium. Hakujibu kwa clinical instruction. Alijibu: Mwambie namfikiria.
Wakati wa break, Maira alimkuta Leila karibu na water dispenser. “Unajua Adrian si monster,” alisema.
“Sijawahi kusema hivyo.”
“Alijenga Nocturne baada ya kuona fragmented clinics zikikosea dozi.”
“Na sasa mfumo wake una risk ambayo yeye hataki kuiachia control.”
Maira akatazama mlango wa hearing. “Kuna tofauti ndogo kati ya kulinda system na kulinda power.”
Leila akasema, “Ndiyo maana checks hazipaswi kutegemea mtu kujua tofauti hiyo kila mara.”
Waliporudi, panel ilitoa interim order. Exclusivity ya Nocturne ilisimamishwa kwa siku thelathini. Licensed network ingeweza kutoa K-17 na protocols chini ya Board monitoring. Company ilitakiwa kutoa technical specs zinazohitajika kwa safe implementation.
Adrian alikaa kimya. Kwa mara ya kwanza, Nocturne ilikuwa imepoteza gatekeeper status kwa order, si tu emergency improvisation.
Panel clerk alianza kurudisha historical exhibits. Leila hakutaka kuzisoma zote; zilikuwapo kuthibitisha older cases, si kumlisha curiosity. Lakini file ya miaka kumi na moja iliyopita ilikuwa wazi kwenye cover page.
Jina la patient likamfanya asimame.
Halikuwa jina la mtu asiyejulikana.
Lilikuwa jina la mama yake Leila.